0001209191-19-023375.txt : 20190403 0001209191-19-023375.hdr.sgml : 20190403 20190403174144 ACCESSION NUMBER: 0001209191-19-023375 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finegan Michael CENTRAL INDEX KEY: 0001391402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19961 FILM NUMBER: 19730318 MAIL ADDRESS: STREET 1: 3451 PLANO PARKWAY CITY: LEWISVILLE STATE: TX ZIP: 75056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orthofix Medical Inc. CENTRAL INDEX KEY: 0000884624 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3451 PLANO PARKWAY CITY: LEWISVILLE STATE: TX ZIP: 75056 BUSINESS PHONE: 214-937-2000 MAIL ADDRESS: STREET 1: 3451 PLANO PARKWAY CITY: LEWISVILLE STATE: TX ZIP: 75056 FORMER COMPANY: FORMER CONFORMED NAME: ORTHOFIX INTERNATIONAL N V DATE OF NAME CHANGE: 19970708 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-01 0 0000884624 Orthofix Medical Inc. OFIX 0001391402 Finegan Michael 3451 PLANO PARKWAY LEWISVILLE TX 75056 0 1 0 0 Chief Strategy Officer Common Stock 2019-04-01 4 A 0 3336 0.00 A 38972 D Common Stock 2019-04-01 4 A 0 7549 0.00 A 46521 D Stock Option (right to buy) 56.20 2019-04-01 4 A 0 11055 0.00 A 2029-04-01 Common Stock 11055 11055 D Performance Share Units 0.00 2019-04-01 4 A 0 6673 0.00 A 2022-04-01 Common Stock 6673 6673 D Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019. Represents time-based vesting restricted stock units that vest on the second anniversary of the grant date, April 1, 2019. These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019. Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2019 to April 1, 2022. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 1, 2019, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. /s/ Kimberley A. Elting, Chief Legal and Administrative Officer, by power of attorney 2019-04-03